We are the largest scientific network in Switzerland and provide advice to policy-makers and society on knowledge-based and socially relevant issues. About us

News

Swiss Academy of Engineering Sciences SATW

Comprendere, sperimentare, innovare: 38 ragazze conquistano il mondo della tecnologia

La loro prima settimana di vacanze estive in laboratorio anziché in piscina: dal 6 al 10 luglio, 38 ragazze provenienti da 13 cantoni hanno partecipato allo Swiss TecLadies Camp a Brunnen, immergendosi nel mondo dell’intelligenza artificiale, della sicurezza informatica e dell’ethical hacking. Il campo mira a suscitare l’interesse delle giovani donne per le professioni tecniche, sfatando al contempo pregiudizi radicati.
  • Swiss Academy of Medical Sciences SAMS

    News

    Swiss Public Health Conference 2027: call for abstracts now open

    How can healthcare systems and their professionals address future challenges? The Swiss Public Health Conference 2027 in Sion will explore this question. Researchers and practitioners are invited to submit their ideas for presentations by February 1, 2027.

  • Swiss Academy of Engineering Sciences SATW

    News

    From controlled earthquakes to the monitoring of unstable slopes

    How do earthquakes occur? Seismologist Anne Obermann from the Swiss Seismological Service, together with a research team from Paris, has applied unsupervised machine learning to data from ETH Zurich’s BedrettoLab. The collaboration was made possible by the Germaine de Staël funding programme. The method identified significantly more seismic events than the previous reference catalogue. This now opens up a broader perspective: initial analyses of data from the Blatten ice and rockfall suggest that the activity of an unstable slope may already be trackable using just a single seismic station. In an interview with the SATW, Obermann explains how a research collaboration gave rise to a new idea for monitoring natural hazards.
  • Swiss Academy of Engineering Sciences SATW

    News

    mRNA 2.0: From the COVID-19 vaccine to a potential treatment for skin cancer

    During the Covid-19 pandemic, mRNA technology gained worldwide recognition. Now it could also transform cancer treatment: the first personalised mRNA vaccine against melanoma has shown promising results in a large Phase III trial. When used in combination with immunotherapy, it reduced the risk of recurrence by 42 per cent. How does a vaccine work that is produced individually for each patient? And what still stands in the way of its widespread use?
more

Contact

Swiss Academies of Arts and Sciences

House of Academies
Laupenstrasse 7
P.O. Box
3001 Bern